Management of dysplasia in the columnar-lined esophagus

Gastroenterol Clin North Am. 1997 Sep;26(3):613-34. doi: 10.1016/s0889-8553(05)70318-6.

Abstract

The management of patients with high-grade dysplasia in Barrett's esophagus is complex and controversial with regard to electing continued endoscopic biopsy surveillance until an early adenocarcinoma is detected or proceeding with partial esophagogastrectomy. Clinical recommendations to patients for either option should be individualized and based on several parameters reflecting patient and clinician factors. Available data on interpretational variation in the diagnosis of dysplasia; limitation of diagnostic errors with the use of a rigorous, systematic endoscopic biopsy protocol; new information on the apparent benign natural history of high-grade dysplasia in some patients; and the morbidity and mortality of esophageal resection all suggest that recommendation for continued endoscopic biopsy surveillance is an appropriate clinical practice in selected patients. Ongoing research investigations on high-grade dysplasia in Barrett's esophagus aim to reduce the potential for diagnostic errors, simplify cancer surveillance, and develop therapeutic interventions that are safer than but as effective as surgery.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adenocarcinoma / diagnosis
  • Barrett Esophagus / complications
  • Barrett Esophagus / diagnosis
  • Barrett Esophagus / therapy*
  • Biopsy
  • Esophageal Neoplasms / diagnosis
  • Esophagus / pathology*
  • Humans